Clopenthixol

• UNSPSC Description:

  Clopenthixol is a thiaquinoline compound with inhibitory effects similar to those of phenothiazine antipsychotics. Clopenthixol is an antagonist of D1 and D2 dopamine receptors. Clopenthixol is mainly used to suppress schizophrenia and other mental disorders[1].

• Target Antigen:

  Dopamine Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein;Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/clopenthixol.html

• Smiles:

  OCCN1CCN(CC/C=C2C3=C(SC4=C/2C=CC=C4)C=CC(Cl)=C3)CC1

• Molecular Weight:

  400.96

• References & Citations:

  [1][Experiences with clopenthixol (Sordinol)]

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  982-24-1